These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Ziagen (abacavir) approved: caution essential. James JS AIDS Treat News; 1999 Jan; (No 310):1, 3-6. PubMed ID: 11366148 [TBL] [Abstract][Full Text] [Related]
4. Intracellular cytokines may model immunoregulation of abacavir hypersensitivity in HIV-infected subjects. King D; Tomkins S; Waters A; Easterbrook PJ; Thurmond LM; Thorborn DE; Raffi F; Kemeny DM; Vyakarnam A J Allergy Clin Immunol; 2005 May; 115(5):1081-7. PubMed ID: 15867870 [TBL] [Abstract][Full Text] [Related]
5. Large lymphadenopathies complicating the abacavir hypersensitivity reaction. García JT; González PR; Hernández-Mora MG; Novoa SR; Quintana FB; Lahoz JG; Vázquez VS AIDS; 2007 Oct; 21(16):2254-6. PubMed ID: 18090059 [No Abstract] [Full Text] [Related]
6. 1592 (abacavir): do not rechallenge after hypersensitivity reaction. James JS AIDS Treat News; 1997 Dec; (No 285):1, 5. PubMed ID: 11364916 [TBL] [Abstract][Full Text] [Related]
7. HLA- B*5701 Allele in HIV-infected Indian Children and its Association with Abacavir Hypersensitivity. Manglani MV; Gabhale YR; Lala MM; Sekhar R; More D Indian Pediatr; 2018 Feb; 55(2):140-141. PubMed ID: 29242412 [TBL] [Abstract][Full Text] [Related]
8. Warning against rechallenge with abacavir. AIDS Patient Care STDS; 1998 Mar; 12(3):229. PubMed ID: 11361938 [No Abstract] [Full Text] [Related]
9. Abacavir hypersensitivity reaction: an update. Hughes CA; Foisy MM; Dewhurst N; Higgins N; Robinson L; Kelly DV; Lechelt KE Ann Pharmacother; 2008 Mar; 42(3):387-96. PubMed ID: 18303141 [TBL] [Abstract][Full Text] [Related]
10. Abacavir at last. Gilden D GMHC Treat Issues; 1998 Mar; 12(3):9. PubMed ID: 11365394 [TBL] [Abstract][Full Text] [Related]
13. Once-daily abacavir in place of twice-daily administration. Goedken AM; Herman RA Ann Pharmacother; 2005; 39(7-8):1302-8. PubMed ID: 15956231 [TBL] [Abstract][Full Text] [Related]
14. Abacavir warning: certain respiratory symptoms can indicate hypersensitivity reaction. AIDS Treat News; 2000 Feb; (No 337):7-8. PubMed ID: 11367210 [TBL] [Abstract][Full Text] [Related]
17. Current trends in screening across ethnicities for hypersensitivity to abacavir. Rodriguez-Nóvoa S; Soriano V Pharmacogenomics; 2008 Oct; 9(10):1531-41. PubMed ID: 18855539 [TBL] [Abstract][Full Text] [Related]
18. A near-fatal hypersensitivity reaction to abacavir: case report and literature review. Shapiro M; Ward KM; Stern JJ AIDS Read; 2001 Apr; 11(4):222-6. PubMed ID: 11392679 [TBL] [Abstract][Full Text] [Related]
19. Hypersensitivity reactions due to abacavir. Newsline People AIDS Coalit N Y; 1998 Feb; ():35-6. PubMed ID: 11367446 [TBL] [Abstract][Full Text] [Related]
20. A severe hypersensitivity reaction to abacavir following re-challenge. Todd S; Emerson CR Int J STD AIDS; 2017 Mar; 28(3):310-311. PubMed ID: 27530904 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]